Telix Pharmaceuticals Limited (TLX.AX)
AUD 25.67
(-0.27%)
AUD 25.67
(-0.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 22.96 Million AUD | 135.06% |
| 2022 | -92.83 Million AUD | 10.87% |
| 2021 | -70.07 Million AUD | -71.45% |
| 2020 | -44.94 Million AUD | -23.18% |
| 2019 | -36.17 Million AUD | -129.75% |
| 2018 | -25.81 Million AUD | -146.36% |
| 2017 | -6.76 Million AUD | -45356.58% |
| 2016 | -14 Thousand AUD | 12.5% |
| 2015 | -16 Thousand AUD | 0.0% |
| 2000 | -994 Thousand AUD | -71.97% |
| 1999 | -578 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 15.74 Million AUD | 0.0% |
| 2023 Q2 | 34.72 Million AUD | 0.0% |
| 2023 FY | - AUD | 135.06% |
| 2023 Q4 | 23.71 Million AUD | 0.0% |
| 2022 Q4 | -7.04 Million AUD | 0.0% |
| 2022 FY | - AUD | 10.87% |
| 2022 Q2 | -60.75 Million AUD | 0.0% |
| 2021 Q4 | -47.28 Million AUD | 0.0% |
| 2021 FY | - AUD | -71.45% |
| 2021 Q2 | -28.78 Million AUD | 0.0% |
| 2020 Q2 | -17.77 Million AUD | 0.0% |
| 2020 FY | - AUD | -23.18% |
| 2020 Q4 | -26.59 Million AUD | 0.0% |
| 2019 FY | - AUD | -129.75% |
| 2019 Q2 | -13.86 Million AUD | 0.0% |
| 2019 Q4 | -22.15 Million AUD | 0.0% |
| 2018 FY | - AUD | -146.36% |
| 2018 Q2 | -10.45 Million AUD | -166.68% |
| 2018 Q1 | -3.92 Million AUD | 39.82% |
| 2018 Q4 | -17.18 Million AUD | 0.0% |
| 2017 Q4 | -6.51 Million AUD | 0.0% |
| 2017 Q2 | 5049.00 AUD | 100.32% |
| 2017 FY | - AUD | -45356.58% |
| 2017 Q1 | -1.59 Million AUD | 0.0% |
| 2016 Q4 | -1.59 Million AUD | 0.0% |
| 2016 FY | - AUD | 12.5% |
| 2015 FY | - AUD | 0.0% |
| 2000 Q3 | -248.5 Thousand AUD | 0.0% |
| 2000 Q2 | -248.5 Thousand AUD | 0.0% |
| 2000 Q1 | -248.5 Thousand AUD | 0.0% |
| 2000 FY | - AUD | -71.97% |
| 1999 Q1 | -144.5 Thousand AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | -248.5 Thousand AUD | -71.97% |
| 1999 Q3 | -144.5 Thousand AUD | 0.0% |
| 1999 Q2 | -144.5 Thousand AUD | 0.0% |
| 1998 Q4 | -144.5 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | -121.349% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 1676.616% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 163.022% |
| Biome Australia Limited | -1.57 Million AUD | 1555.155% |
| Patrys Limited | -3.49 Million AUD | 757.646% |
| Orthocell Limited | -11.68 Million AUD | 296.608% |
| Imugene Limited | -147.97 Million AUD | 115.52% |
| Noxopharm Limited | -5.94 Million AUD | 486.276% |
| PYC Therapeutics Limited | -38.11 Million AUD | 160.25% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 303.243% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 419.607% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 391.176% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 330.809% |
| CSL Limited | 4.73 Billion AUD | 99.515% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 359.998% |
| Bio-Gene Technology Limited | -2.97 Million AUD | 871.97% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 55.718% |
| Starpharma Holdings Limited | -12.57 Million AUD | 282.603% |
| Nanollose Limited | -1.14 Million AUD | 2100.695% |
| Memphasys Limited | -3.3 Million AUD | 794.315% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | 3287.77% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | 1378.528% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 603.685% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 264.993% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | 914.941% |
| Race Oncology Limited | -14.2 Million AUD | 261.694% |
| Nyrada Inc. | -4.59 Million AUD | 599.673% |
| Dimerix Limited | -24.95 Million AUD | 192.017% |
| PharmAust Limited | -9.45 Million AUD | 342.982% |
| Immutep Limited | -42.87 Million AUD | 153.565% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 151.438% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 217.343% |
| BTC Health Limited | 1.05 Million AUD | -2076.28% |
| Acrux Limited | -7.93 Million AUD | 389.573% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 88.474% |
| Biotron Limited | -5.04 Million AUD | 555.67% |
| Tissue Repair Ltd | -5.77 Million AUD | 497.68% |
| AdAlta Limited | -5.3 Million AUD | 533.1% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 150.612% |
| Hexima Limited | -995.54 Thousand AUD | 2406.882% |
| AnteoTech Limited | -11.57 Million AUD | 298.48% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 135.585% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 207.548% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 808.278% |
| Actinogen Medical Limited | -12.92 Million AUD | 277.739% |
| Immuron Limited | -6.19 Million AUD | 470.877% |
| Argenica Therapeutics Limited | -1.89 Million AUD | 1310.271% |